Psychedelic Business Spotlight — January 28
This week in psychedelic business news: A major player begins manufacturing; another rebrands; and one of the biggest gets bigger.
mydecine innovations
Psychedelic Business Spotlight – January 21
Catch up on some of the biggest psychedelic business developments that unfolded in the last week.
Psychedelic Business Spotlight – December 10
This week in psychedelic business news: Wesana Health files a new patent, Silo Pharma is granted a patent, and 2 companies explore a merger.
Psychedelic Business Spotlight: November 5
This week in psychedelic business news: DEA grants Cybin a Schedule I manufacturing license; PharmaTher partners with Revive Therapeutics on microneedle patch technology; Mydecine patents nanotechnology.
Psychedelic Business Spotlight: October 29
This week in psychedelic business news: MindMed’s MDMA research pipeline to treat Autism Spectrum Disorder; Cybin EMBARKs; Awakn and MindCure partner to heal alcoholism.
Johns Hopkins and Mydecine Partner to Further Psychedelic Therapy for Smoking Addiction
“Cigarette smoking remains one of the most difficult addictions to treat and contributes to more deaths than all the other substances combined, making this research vital,” says Mydecine Innovations Chief Medical Officer Dr. Rakesh Jetly.
End of content
End of content